Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Revue du rhumatisme
Volume 78, n° 5
pages 404-406 (octobre 2011)
Doi : 10.1016/j.rhum.2011.05.011
accepted : 16 May 2011
Traitements biologiques dans la spondylarthrite : au-delà des anti-TNF
 

Daniel Wendling , Clément Prati
Service de rhumatologie, université de Franche-Comté, CHU de Besançon, boulevard Fleming, 25030 Besançon, France 

Auteur correspondant.

Mots clés : Spondylarthrite, Biothérapies, Abatacept, Tocilizumab, Rituximab, Anti-IL-17



 Ne pas utiliser, pour citation, la référence française de cet article, mais la référence anglaise de Joint Bone Spine (doi:10.1016/j.jbspin.2011.05.023).



© 2011  Société Française de Rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline